Sector ratings Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-07 EDT			5-day change	1st Jan Change
496.07 ^USD	+2.49%		+3.98%	+9.42%

08-05	Rothschild & Co Redburn Adjusts Vertex Pharmaceuticals Price Target to $580 From $570	MT
08-04	Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
VERTEX PHARMACEUTICALS INCORPORATED	126B		AA
ELI LILLY AND COMPANY	1,057B		A
JOHNSON & JOHNSON	625B	-	BBB	-	-
ABBVIE INC.	435B		AA	-
ROCHE HOLDING AG	363B		AA
NOVARTIS AG	296B		AAA
ASTRAZENECA PLC	249B		A
AMGEN INC.	222B		A
NOVO NORDISK A/S	209B		A
GILEAD SCIENCES, INC.	165B		AA
PFIZER INC.	153B		A
BRISTOL-MYERS SQUIBB COMPANY	132B		A
GSK PLC	106B		AA
SANOFI	104B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	71.54B		AA
BAYER AG	56.57B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	56.09B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	53.41B		AA
HALEON PLC	43.91B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	41.2B		-
Average	228.22B		AA
Weighted average by Cap.			AA